ICH Q3D Guideline is focused to limit the presence of potentially toxic elemental impurities in the human medicines. Deadline for implementing this normative expires next December 2017, thus, last Thursday Azierta along with its European partners, Kymos, Socosur and Maas & Peither arrange a webinar to review key aspects for a successful implantation of the guideline.
Results were remarkable since we had around 250 participants from more than fifteen countries across Europe (Spain, UK, Germany, France, Belgium, Czech Republic , Portugal, Denmark and Ireland among others). Attendees were especially interested in the case study reviewed and there was a significant amount of questions received through the session’s chat. Participants’ appraisal of the webinar was mainly good and excellent.
Given this results we are already planning new sessions. Follow our social media for all details.
At Azierta, our team of toxicological experts, design tailored action plans in order to implement the ICH Q3D. Visit us at: https://azierta.eu/toxicologia/analisis-riesgos-impurezas-elementales-ichq3d/